[Prolonged therapy of chronic pyelonephritis].
D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D001437:Bacteriuria / Q000382:microbiology; D013293:Enterococcus faecalis / Q000302:isolation & purification; D004926:Escherichia coli / Q000302:isolation & purification; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D011704:Pyelonephritis / Q000188:drug therapy* / Q000382:microbiology; D011743:Pyrimidines / Q000627:therapeutic use*; D013297:Streptococcus pyogenes / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000892:Anti-Infective Agents, Urinary; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Beitrag zur Langzeittherapie der chronischen Pyelonephritis.